Table 6.
Impact of APH(3′)-IIIa mutations on resistance, enzyme-drug binding affinity, and catalysis
APH(3′)-IIIa | MIC (μM)a | Ka (M−1)b | Km (μM)c | kcat (s−1)c |
---|---|---|---|---|
Neo | ||||
none | 6 | n.a. | n.a. | n.a. |
wt | 1600 | (4.2 ± 1.5) × 107 | 18.2 ± 1.6 | 1.7 ± 0.1 |
E157A | 800 | (7.6 ± 0.2) × 106 | 14.7 ± 1.7 | 1.3 ± 0.1 |
E160A | 1600 | (1.4 ± 0.1) × 106 | 25.2 ± 5.1 | 2.4 ± 0.2 |
D190A | 6 | (1.9 ± 0.2) × 106 | n.d. | n.d. |
D193A | 200 | (1.9 ± 0.4) × 107 | 5.9 ± 1.0 | 0.7 ± 0.1 |
E230A | 1600 | (9.1 ± 3.4) × 106 | 10.0 ± 1.0 | 1.3 ± 0.1 |
D261A | 12 | (1.3 ± 0.3) × 105 | 3.3 ± 1.5 | 0.02 ± 0.01 |
E262A | 6 | (2.1 ± 0.1) × 104 | 21.2 ± 5.1 | 1.9 ± 0.1 |
ΔF264 | 12 | (1.4 ± 0.1) × 104 | 10.7 ± 1.8 | 0.9 ± 0.1 |
KanB | ||||
none | 6 | n.a. | n.a. | n.a. |
wt | 1600 | (1.7 ± 0.2) × 107 | 19.3 ± 6.8 | 1.9 ± 0.2 |
E157A | 800 | (2.2 ± 0.9) × 107 | 44.1 ± 5.7 | 2.5 ± 0.1 |
E160A | 400 | (2.1 ± 0.1) × 105 | 42.9 ± 7.2 | 2.7 ± 0.2 |
D190A | 6 | (1.8 ± 0.1) × 106 | n.d. | n.d. |
D193A | 1600 | (1.3 ± 0.1) × 107 | 38.7 ± 9.1 | 2.7 ± 0.2 |
E230A | 1600 | (1.1 ± 0.1) × 107 | 39.8 ± 4.5 | 2.1 ± 0.1 |
D261A | 12 | (1.4 ± 0.1) × 105 | 9.1 ± 1.0 | 0.2 ± 0.01 |
E262A | 6 | (2.2 ± 0.6) × 103 | 36.4 ± 4.6 | 1.2 ± 0.1 |
ΔF264 | 12 | (6.3 ± 0.2) × 103 | 16.4 ± 3.0 | 0.9 ± 0.1 |
Antibacterial activities were assayed in at least two independent experiments. For each drug, the MIC (minimal inhibitory concentration) value obtained was identical in each of the experiments.
Values of Ka were derived from fits of the ITC profiles shown in Figure 7. The indicated uncertainties reflect the standard deviations of the experimental data from the fitted curves. n.a. denotes not applicable.
Values of Km and kcat were derived from the fits of v versus [S] plots as described in the Materials and Methods, with the indicated uncertainties reflecting the standard deviations of the experimental data from the fitted curves. n.d. denotes not detectable.